Health
Surprising discovery reveals new target for aggressive lung adenocarcinoma – News-Medical.Net
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer. These drugs inhibit cancer cells by thwarting the molecular changes that drive them to grow while largely sparing healthy tissues. But for the other two-thirds of people with this type of cancer, there are fewer treatment options.
A team from Memorial Sloan Kettering is reporting new findings about a particularly aggressive subset of lung adenocarcinomas that are…
Continue Reading
